CD95 ligand expression mediates immune escape in breast cancer

被引:0
|
作者
C Moers
M Müschen
MW Beckmann
P Mallmann
机构
[1] Klinik für Geburtshilfe und Gynäkologie,Klinik für Geburtshilfe und Gynäkologie
[2] Klinik für Genetik,undefined
[3] Universität zu Köln,undefined
[4] Universität Erlangen,undefined
关键词
Breast Cancer; Cancer Patient; Breast Cancer Cell; Breast Cancer Patient; Culture Supernatant;
D O I
10.1186/bcr406
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] CD95 ligand expression as a mechanism of immune escape in breast cancer
    Müschen, M
    Moers, C
    Warskulat, U
    Even, J
    Niederacher, D
    Beckmann, MW
    IMMUNOLOGY, 2000, 99 (01) : 69 - 77
  • [2] CD95 ligand expression in dedifferentiated breast cancer
    C Moers
    M Müschen
    MW Beckmann
    P Mallmann
    Breast Cancer Research, 3 (Suppl 1)
  • [3] CD95 ligand expression in dedifferentiated breast cancer
    Müschen, M
    Moers, C
    Warskulat, U
    Niederacher, D
    Betz, B
    Even, J
    Lim, A
    Josien, R
    Beckmann, MW
    Häussinger, D
    JOURNAL OF PATHOLOGY, 1999, 189 (03): : 378 - 386
  • [4] Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack
    Uckan, D
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (04): : 223 - 234
  • [5] CD95 ligand expression as a criterion of malignant transformation in breast cancer
    Müschen, M
    Beckmann, MW
    JOURNAL OF PATHOLOGY, 2000, 191 (04): : 468 - 469
  • [6] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [7] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559
  • [8] Erratum: The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 885 - 886
  • [9] CD95 ligand expression as a criterion of malignant transformation in breast cancer -: Reply
    Müllauer, L
    JOURNAL OF PATHOLOGY, 2000, 191 (04): : 469 - 470
  • [10] CD95 and CD95 ligand expression in very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    MacKie, RM
    Gore, ME
    Bunker, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 554 - 554